Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06786533
Title Clinical Study of Anti-FLT3 CAR-T Cells for the Treatment of Relapsed/refractory AML
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Hemogenyx Pharmaceuticals LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA